Patterns of adherence to oral methadone: Implications for prescribers

Journal of Substance Abuse Treatment

Volumn 35, Issue 2, 2008, Pages 109-115

  Haskew, Michael ^a   Wolff, Kim ^b   Dunn, John ^a   Bearn, Jenny ^c  

^a CAMDEN AND ISLINGTON NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adherence; Compliance; Methadone; Prevalence; Treatment

Indexed keywords

METHADONE; OPIATE;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL SECRECY; STRUCTURED INTERVIEW; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADOLESCENT; ADULT; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; FEMALE; HUMANS; LOGISTIC MODELS; LONDON; MALE; METHADONE; MIDDLE AGED; NARCOTICS; PATIENT COMPLIANCE; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 47549094900     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2007.08.013     Document Type: Article

References (32)

1. Bale R.N., Van Stone W.W., Engelsing T.M., Zarcone V.P., and Kuldau J.M. The validity of self-reported heroin use. International Journal of the Addictions 16 (1981) 1387-1398
2. Ball J.C. The reliability and validity of interview data obtained from 59 narcotic drug addicts. American Journal of Sociology 72 (1966) 650-654
3. Ball J.C., and Ross A. The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcomes (1991), Springer-Verlag, New York 1991
4. Best D., Gossop M., Marsden J., Farrell M., and Strang J. Time of day of methadone consumption and illicit heroin use. Drug and Alcohol Dependence 49 (1997) 49-54
5. Chutuape M.A., Silverman K., and Stizer M. Use of methadone take-home contingencies with persistent opiate and cocaine abusers. Journal of Substance Abuse Treatment 16 (1999) 23-30
6. Clark L.T. Improving compliance and increasing control of hypertension: Needs of special hypertensive populations. American Heart Journal 121 (1991) 664-669
7. Darke S., Ross J., and Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug and Alcohol Dependence 43 (1996) 191-198
8. Dekker F.W., Dieleman F.E., Kaptein A.A., and Mulder J.D. Compliance with pulmonary medication in general practice. European Respiratory Journal 6 (1993) 886-890
9. Department of Health, Welsh Office, Scottish Home and Health Department, and Northern Ireland Office. Drug misuse and dependence: Guidelines on clinical management (1999), HMSO, London
10. DiMatteo M.R. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care 42 (2004) 200-210
11. Eap C.B., Biclin T., and Baumain P. Interindividual variability of the clinical pharmacokinetics of methadone: Implications for the treatment of opioid dependence. Clinical Pharmacokinetics 41 (2002) 1153-1193
12. Fairley C.K., Permana A., and Read T.R.H. Long term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Medicine 6 (2005) 366-369
13. Fountain J., Griffiths P., Farrell M., Gossop M., and Strang J. Diversion tactics: How a sample of drug misusers in treatment obtained surplus drugs to sell on the illicit market. International Journal of Drug Policy 9 (1998) 159-167
14. Gossop M., Green L., Phillips G., and Bradley B. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. British Journal of Psychiatry 154 (1989) 348-353
15. Government Office Statistics. Islington borough statistics. Available online: (2004). http://www.go-london.gov.uk/boroughinfo/borough.aspx?bid=19 [accessed on 5/8/06]
16. Greenwald M.K. Heroin craving and drug use in opioid maintained volunteers: Effects of methadone dose variations. Exp Clin Psychopharmacol 10 (2002) 39-46
17. Lutfey K.E., and Wishner W.J. Beyond "compliance" is "adherence." Improving the prospect of diabetes care. Diabetes Care 22 (1999) 635-639
18. Magura S., and Lipton D.S. The accuracy of drug use monitoring in methadone treatment. Journal of Drug Issues 18 (1988) 317-326
19. Marsden J., Gossop M., Stewart D., Best D., Farrell M., Lehmann P., et al. The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome. Addiction 93 (1998) 1857-1868
20. Mattick R.P., Kimber J., Breen C., and Davoli M. Buprenorphine maintenance vs. placebo or methadone maintenance for opioid dependence (Cochrane review). The Cochrane Library (2004)
21. Mitchell T.B., Dyer K.R., Newcombe D., Somogyi A.A., and White J.M. Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients. Addiction (2006) 170-174
22. National Treatment Agency for Substance Misuse. Press release; October. Available online: (2005). http://www.nta.nhs.uk/ [accessed on 5/08/06]
23. Pani P.P., Pirastu R., Ricci A., and Gessa G.L. Prohibition of take-home dosages: Negative consequences on methadone maintenance treatment. Drug and Alcohol Dependence 41 (1996) 81-84
24. Seymore A., Black M., Jay J., Cooper G., Weir C., and Oliver J. The role of methadone in drug-related deaths in the west of Scotland. Addiction 98 (2003) 995-1002
25. Simpson S.H., Eurich D.T., Majumdar S.R., Padwal R.S., Tsuyuki J.V., and Johnson J.A. A meta-analysis of the association between adherence to drug therapy and mortality. British Medical Journal 333 (2006) 15-19
26. Smyth B.P., Barry J., Lane A., Cotter M., O'Neill M., Quinn C., et al. In-patient treatment of opiate dependence: Medium-term follow-up outcomes. British Journal of Psychiatry 187 (2005) 360-365
27. Spunt B., Hunt D.E., Lipton D.S., and Goldsmith D.S. Methadone diversion: A new look. Journal of Drug Issues 16 (1986) 569-583
28. Ward J., Hall W., and Mattick R.P. Role of maintenance treatment in opioid dependence. The Lancet 353 (1999) 221-226
29. Weiss R.D. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 99 (2004) 1382-1392
30. White J.M., Ryan C.F., and Ali R.L. Improvements in retention rates and changes in client group with methadone maintenance streaming. Drug and Alcohol Review 15 (1996) 83-88
31. Wolff K. Characterization of methadone overdose: Clinical considerations and the scientific evidence. Therapeutic Drug Monitoring 24 (2002) 457-470
32. Wolff K., Farrell M., Marsden J., Monteiro M.G., Ali R., Welch S., et al. A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction 94 (1999) 1279-1298